FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Marchina Van Der Ende

Research Profile

Disorders

Chemicals & Drugs

Living Beings

HIV-1
HIV-2

Procedures

Concepts & Ideas

Geographic Areas

Netherlands

Co-author Network

Publications

TOP 3
Vania Baptista Lopes; Martin Schutten; Robert A de Man; Theodora E M S de Vries-Sluijs; Abdel El Barzouhi; Bettina E Hansen; Robert J Hassing; Marchina E Van Der Ende
Long-term response rates of successful hepatitis B vaccination in HIV-infected patients.
Hangxing Yu; Alexandra Borch; Rob A Gruters; Mohammad Khalid; Julia Krämer; Daniela Krnavek; Xuehua Li; Albert D Osterhaus; Christina M Stürzel; Shariq M Usmani; Marchina E Van Der Ende; Frank Kirchhoff
The efficiency of Vpx-mediated SAMHD1 antagonism does not correlate with the potency of viral control in HIV-2-infected individuals.
J N L Schouten; Marchina E Van Der Ende; M van der Valk; J Verheij; Bettina E Hansen; T Koëter; M Komuta; H H M Rossing; H L A Janssen
Risk factors and outcome of HIV-associated idiopathic noncirrhotic portal hypertension.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Marchina Van Der Ende (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Vania Baptista Lopes; Martin Schutten; Robert A de Man; Theodora E M S de Vries-Sluijs; Abdel El Barzouhi; Bettina E Hansen; Robert J Hassing; Marchina E Van Der Ende
Long-term response rates of successful hepatitis B vaccination in HIV-infected patients.
Vaccine 2013;31(7):1040-4.
2013: Hangxing Yu; Alexandra Borch; Rob A Gruters; Mohammad Khalid; Julia Krämer; Daniela Krnavek; Xuehua Li; Albert D Osterhaus; Christina M Stürzel; Shariq M Usmani; Marchina E Van Der Ende; Frank Kirchhoff
The efficiency of Vpx-mediated SAMHD1 antagonism does not correlate with the potency of viral control in HIV-2-infected individuals.
Retrovirology 2013;10():27.
2012: J N L Schouten; Marchina E Van Der Ende; M van der Valk; J Verheij; Bettina E Hansen; T Koëter; M Komuta; H H M Rossing; H L A Janssen
Risk factors and outcome of HIV-associated idiopathic noncirrhotic portal hypertension.
Alimentary pharmacology & therapeutics 2012;36(9):875-85.
2012: Eric M van der Snoek; Jan B Aans; Jan C den Hollander; Henricus J C M Sterenborg; Marchina E Van Der Ende; Dominic J Robinson
Photodynamic therapy with systemic meta-tetrahydroxyphenylchlorin in the treatment of anal intraepithelial neoplasia, grade 3.
Lasers in surgery and medicine 2012;44(8):637-44.
2012: Roeland Zoutendijk; Robert A de Man; Theodora E M S de Vries-Sluijs; Bettina E Hansen; Frank P Kroon; Jan W Mulder; Jurrien G P Reijnders; Clemens Richter; Milan J Sonneveld; Annemiek A van der Eijk; Marchina E Van Der Ende; Hans L Zaaijer; Harry L A Janssen
Hepatitis B surface antigen declines and clearance during long-term tenofovir therapy in patients coinfected with HBV and HIV.
The Journal of infectious diseases 2012;206(6):974-80.
2012: Eric M van der Snoek; Jan C den Hollander; H A M Neumann; M Schutten; Marchina E Van Der Ende; G J J van Doornum
Use of highly active antiretroviral therapy is associated with lower prevalence of anal intraepithelial neoplastic lesions and lower prevalence of human papillomavirus in HIV-infected men who have sex with men.
Sexually transmitted diseases 2012;39(7):495-500.
2012: Mohammad Khalid; Jerome Feldman; Matthias Geyer; Rob A Gruters; Albert D Osterhaus; Sarah Rowland-Jones; Daniel Sauter; Jan Schmokel; Shariq M Usmani; Marchina E Van Der Ende; Hangxing Yu; Frank Kirchhoff
Efficient Nef-mediated downmodulation of TCR-CD3 and CD28 is associated with high CD4+ T cell counts in viremic HIV-2 infection.
Journal of virology 2012;86(9):4906-20.
2012: Sandra G Heil; Jan Lindemans; Paul W Schenk; Marchina E Van Der Ende; Ilse van der Heiden; David Burger; Ron H N van Schaik
Associations between ABCB1, CYP2A6, CYP2B6, CYP2D6, and CYP3A5 alleles in relation to efavirenz and nevirapine pharmacokinetics in HIV-infected individuals.
Therapeutic drug monitoring 2012;34(2):153-9.
2012: Ingrid J M Snijdewind; Kees Boer; Frank de Wolf; Mieke H Godfried; Jeannine F J B Nellen; Colette Smit; Marchina E Van Der Ende
Hcv coinfection, an important risk factor for hepatotoxicity in pregnant women starting antiretroviral therapy.
The Journal of infection 2012;64(4):409-16.
2012: Ingrid J M Snijdewind; Marchina E Van Der Ende; Jeroen J A van Kampen; Pieter L A Fraaij; Albert D M E Osterhaus; Rob A Gruters
Current and future applications of dried blood spots in viral disease management.
Antiviral research 2012;93(3):309-21.
2012: Marieke Pingen; Martin Schutten; Birgitte B Simen; Marchina E Van Der Ende; Susan Walsh; Johanna Brodin; Sander Dinant; Manfred Kayser; Mattias Mild; Jan L Nouwen; Jan Albert; Charles A B Boucher
Therapy failure resulting from superinfection by a drug-resistant HIV variant.
Antiviral therapy 2012;17(8):1621-5.
2011: Theodora E M S de Vries-Sluijs; Bettina E Hansen; Gerard J J van Doornum; Robert H Kauffmann; Eliane M S Leyten; Tania Mudrikova; Kees Brinkman; Jan G den Hollander; Frank P Kroon; Harry L A Janssen; Marchina E Van Der Ende; Robert A de Man
A randomized controlled study of accelerated versus standard hepatitis B vaccination in HIV-positive patients.
The Journal of infectious diseases 2011;203(7):984-91.
2011: Roland J.W. Meesters, Ph.D.; Jeroen J A van Kampen; Rachel D Scheuer; Marchina E Van Der Ende; Rob A Gruters; Theo M Luider
Determination of the antiretroviral drug tenofovir in plasma from HIV-infected adults by ultrafast isotope dilution MALDI-triple quadrupole tandem mass spectrometry.
Journal of mass spectrometry : JMS 2011;46(3):282-9.
2011: Merlijn A Kramer; Marion Cornelissen; Dimitrios Paraskevis; Maria Prins; Roel A Coutinho; Ard I van Sighem; Lesley Sabajo; Ashley J Duits; Cai N Winkel; Jan M Prins; Marchina E Van Der Ende; Robert H Kauffmann; E L M Op de Coul
HIV transmission patterns among The Netherlands, Suriname, and The Netherlands Antilles: a molecular epidemiological study.
AIDS research and human retroviruses 2011;27(2):123-30.
2010: Theodora E M S de Vries-Sluijs; Jurriën G P Reijnders; Bettina E Hansen; Hans L Zaaijer; Jan M Prins; Suzan D Pas; Martin Schutten; Andy I M Hoepelman; Clemens Richter; Jan W Mulder; Robert A de Man; Harry L A Janssen; Marchina E Van Der Ende
Long-term therapy with tenofovir is effective for patients co-infected with human immunodeficiency virus and hepatitis B virus.
Gastroenterology 2010;139(6):1934-41.
2010: Matthijs van Luin; Marchina E Van Der Ende; Clemens Richter; Mirjam Visser; Diari Faraj; Andre J A M van der Ven; Luc Gelinck; Frank P Kroon; Ferdinand W Wit; Ron H N Van Schaik; Paul F M Kuks; David M Burger
Lower atovaquone/proguanil concentrations in patients taking efavirenz, lopinavir/ritonavir or atazanavir/ritonavir.
AIDS (London, England) 2010;24(8):1223-6.
2009: Matthijs van Luin; Luuk Gras; Clemens Richter; Marchina E Van Der Ende; Jan M Prins; Frank de Wolf; David Burger; Ferdinand W Wit
Efavirenz dose reduction is safe in patients with high plasma concentrations and may prevent efavirenz discontinuations.
Journal of acquired immune deficiency syndromes (1999) 2009;52(2):240-5.
2009: Eric M van der Snoek; Arien Amelink; Marchina E Van Der Ende; Jan C den Hollander; Jan G den Hollander; Frank P Kroon; Robert Vriesendorp; H A Martino Neumann; Dominic J Robinson
Photodynamic therapy with topical metatetrahydroxychlorin (Fosgel) is ineffective for the treatment of anal intraepithelial neoplasia, grade III.
Journal of acquired immune deficiency syndromes (1999) 2009;52(1):141-3.
2009: Luc B Gelinck; Marchina E Van Der Ende
Early versus deferred antiretroviral therapy for HIV.
The New England journal of medicine 2009;361(8):823; author reply 823-4.
2009: Anne Roefs; Marchina E Van Der Ende; Jan IJzermans; Willem Weimar; Teun van Gelder
Long-term survival after kidney transplantation in an HIV-positive patient.
Clinical transplantation 2009;23(2):278-81.
2008: I Marion de Boer-van der Kolk; Mirjam A G Sprangers; Marchina E Van Der Ende; Gerrit Schreij; Frank de Wolf; Pythia T Nieuwkerk
Lower perceived necessity of HAART predicts lower treatment adherence and worse virological response in the ATHENA cohort.
Journal of acquired immune deficiency syndromes (1999) 2008;49(4):460-2.
2008: Ferdinand W N M Wit; Anouk M Kesselring; Luuk Gras; Clemens Richter; Marchina E Van Der Ende; Kees Brinkman; Joep M A Lange; Frank de Wolf; Peter Reiss
Discontinuation of nevirapine because of hypersensitivity reactions in patients with prior treatment experience, compared with treatment-naive patients: the ATHENA cohort study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;46(6):933-40.
2008: Hetty Blaak; Patrick H M Boers; Marchina E Van Der Ende; Hanneke Schuitemaker; Albert D M E Osterhaus
CCR5-restricted HIV type 2 variants from long-term aviremic individuals are less sensitive to inhibition by beta-chemokines than low pathogenic HIV type 1 variants.
AIDS research and human retroviruses 2008;24(3):473-84.
2008: Theodora E M S de Vries-Sluijs; Bettina E Hansen; G J J van Doornum; Tirza Springeling; Nicole M Evertsz; Robert A de Man; Marchina E Van Der Ende
A prospective open study of the efficacy of high-dose recombinant hepatitis B rechallenge vaccination in HIV-infected patients.
The Journal of infectious diseases 2008;197(2):292-4.
2007: Marchina E Van Der Ende; Jan W Mulder; Marcel van den Berge; Willem L Blok; Martin Schutten
Complete clinical and virological remission of refractory HIV-related Kaposi's sarcoma with pegylated interferon alpha.
AIDS (London, England) 2007;21(12):1661-2.
2007: Kees Boer; Jeannine F J B Nellen; D Patel; Sarah Timmermans; Claire Tempelman; M Wibaut; M A Sluman; Marchina E Van Der Ende; Mieke H Godfried
The AmRo study: pregnancy outcome in HIV-1-infected women under effective highly active antiretroviral therapy and a policy of vaginal delivery.
BJOG : an international journal of obstetrics and gynaecology 2007;114(2):148-55.
2006: Hetty Blaak; Marchina E Van Der Ende; Patrick H M Boers; Hanneke Schuitemaker; Albert D M E Osterhaus
In vitro replication capacity of HIV-2 variants from long-term aviremic individuals.
Virology 2006;353(1):144-54.
2006: T E M S de Vries-Sluijs; Annemiek A van der Eijk; Bettina E Hansen; A D M E Osterhaus; Robert A de Man; Marchina E Van Der Ende
Wild type and YMDD variant of hepatitis B virus: no difference in viral kinetics on lamivudine/tenofovir therapy in HIV-HBV co-infected patients.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2006;36(1):60-3.
2006: David Burger; Ilse van der Heiden; Charles J L la Porte; Marchina E Van Der Ende; Paul Groeneveld; Clemens Richter; Peter P Koopmans; Frank P Kroon; Herman Sprenger; Jan Lindemans; Paul Schenk; Ron van Schaik
Interpatient variability in the pharmacokinetics of the HIV non-nucleoside reverse transcriptase inhibitor efavirenz: the effect of gender, race, and CYP2B6 polymorphism.
British journal of clinical pharmacology 2006;61(2):148-54.
2005: Charles J L la Porte; Emile F Schippers; Marchina E Van Der Ende; Peter P Koopmans; Willem L Blok; Robbert H Kauffmann; Frank P Kroon; David Burger
Pharmacokinetics of once-daily lopinavir/ritonavir and the influence of dose modifications.
AIDS (London, England) 2005;19(10):1105-7.
2005: Kristel M Crommentuyn; Alwin D Huitema; Kees Brinkman; Marchina E Van Der Ende; Frank de Wolf; Jos H Beijnen
Therapeutic drug monitoring of nevirapine reduces pharmacokinetic variability but does not affect toxicity or virologic success in the ATHENA study.
Journal of acquired immune deficiency syndromes (1999) 2005;39(2):249-50.
2005: Sarah Timmermans; Claire Tempelman; Mieke H Godfried; Jeannine F J B Nellen; Jeanne P Dieleman; Herman Sprenger; Margriet Ee Schneider; Frank de Wolf; Kees Boer; Marchina E Van Der Ende
Nelfinavir and nevirapine side effects during pregnancy.
AIDS (London, England) 2005;19(8):795-9.
2005: Jan G Den Hollander; Bart J A Rijnders; G J J van Doornum; Marchina E Van Der Ende
Sexually transmitted reinfection with a new hepatitis C genotype during pegylated interferon and ribavirin therapy.
AIDS (London, England) 2005;19(6):639-40.
2005: Ferdinand W N M Wit; Daniel H Blanckenberg; Kees Brinkman; Jan M Prins; Marchina E Van Der Ende; M M E Schneider; Jan W Mulder; Frank de Wolf; Joep Ma Lange
Safety of long-term interruption of successful antiretroviral therapy: the ATHENA cohort study.
AIDS (London, England) 2005;19(3):345-8.
2005: Hetty Blaak; Patrick H M Boers; Rob A Gruters; Hanneke Schuitemaker; Marchina E Van Der Ende; A D M E Osterhaus
CCR5, GPR15, and CXCR6 are major coreceptors of human immunodeficiency virus type 2 variants isolated from individuals with and without plasma viremia.
Journal of virology 2005;79(3):1686-700.
2004: Th A Ruys; Jan G Den Hollander; Marcel G H M Beld; Marchina E Van Der Ende; J T M van der Meer
[Sexual transmission of hepatitis C in homosexual men].
Nederlands tijdschrift voor geneeskunde 2004;148(47):2309-12.
2004: Claire Tempelman; Sarah Timmermans; Mieke H Godfried; Jeanne P Dieleman; Kees Boer; Marchina E Van Der Ende
[Highly active antiretroviral therapy (HAART) in HIV-positive pregnant women in the Netherlands, 1997-2003: safe, effective and with few side effects].
Nederlands tijdschrift voor geneeskunde 2004;148(41):2021-5.
2004: Frank van Leth; Ferdinand W N M Wit; Peter Reiss; J K M E Schattenkerk; Marchina E Van Der Ende; M M E Schneider; Jan W Mulder; P H J Frissen; Frank de Wolf; Joep M A Lange
Differential CD4 T-cell response in HIV-1-infected patients using protease inhibitor-based or nevirapine-based highly active antiretroviral therapy.
HIV medicine 2004;5(2):74-81.
2004: David Burger; Jan M Prins; Marchina E Van Der Ende; Rob E Aarnoutse
The effect of nevirapine on the pharmacokinetics of indinavir/ritonavir 800/100 mg BID.
Journal of acquired immune deficiency syndromes (1999) 2004;35(1):97-8.
2003: David Burger; Rob E Aarnoutse; Jeanne P Dieleman; Inge C Gyssens; Jan Nouwen; Siem de Marie; Peter P Koopmans; Michael Stek; Marchina E Van Der Ende
A once-daily HAART regimen containing indinavir + ritonavir plus one or two nucleoside reverse transcriptase inhibitors (PIPO study).
Antiviral therapy 2003;8(5):455-61.
2003: Marchina E Van Der Ende; Jan M Prins; Kees Brinkman; Monique Keuter; Jan Veenstra; Sven A Danner; Hubert G M Niesters; Albert D M E Osterhaus; Martin Schutten
Clinical, immunological and virological response to different antiretroviral regimens in a cohort of HIV-2-infected patients.
AIDS (London, England) 2003;17 Suppl 3():S55-61.
2003: David Burger; Patricia W H Hugen; Rob E Aarnoutse; Richard Hoetelmans; Marielle Jambroes; Pythia T Nieuwkerk; Gerrit Schreij; M M E Schneider; Marchina E Van Der Ende; Joep M A Lange
Treatment failure of nelfinavir-containing triple therapy can largely be explained by low nelfinavir plasma concentrations.
Therapeutic drug monitoring 2003;25(1):73-80.
2003: Theodora E M S de Vries-Sluijs; Jeanne P Dieleman; Dennis Arts; Alwin D R Huitema; Jos H Beijnen; Martin Schutten; Marchina E Van Der Ende
Low nevirapine plasma concentrations predict virological failure in an unselected HIV-1-infected population.
Clinical pharmacokinetics 2003;42(6):599-605.
2002: Marchina E Van Der Ende; Rosa M Regez; Gerrit Schreij; J T M van der Meer; Sven A Danner
Post-exposure prophylaxis.
International journal of STD & AIDS 2002;13 Suppl 2():30-4.
2002: E L M Kooiman; Jeanne P Dieleman; Inge C Gyssens; Pythia T Nieuwkerk; Siem de Marie; Marchina E Van Der Ende
[Treatment adherence amongst HIV-infected patients in Rotterdam: poorer prognosis independent of nationality in heterosexual infected patients, intravenous drug users, Negroid and Latin-American patients].
Nederlands tijdschrift voor geneeskunde 2002;146(25):1183-7.
2002: Jeanne P Dieleman; Miriam C J M Sturkenboom; Ferdinand W N M Wit; Marielle Jambroes; Jan W Mulder; Jacob H Ten Veen; Job Juttmann; Bruno H Ch Stricker; Joep M A Lange; Marchina E Van Der Ende
Low risk of treatment failure after substitution of nevirapine for protease inhibitors among human immunodeficiency virus-infected patients with virus suppression.
The Journal of infectious diseases 2002;185(9):1261-8.
2002: Leonieke M M Wolters; Hubert G M Niesters; Bettina E Hansen; Marchina E Van Der Ende; Frank P Kroon; C Richter; Kees Brinkman; Pieter L Meenhorst; Robert A de Man
Development of hepatitis B virus resistance for lamivudine in chronic hepatitis B patients co-infected with the human immunodeficiency virus in a Dutch cohort.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2002;24(3):173-81.
2001: Pythia T Nieuwkerk; Mirjam A G Sprangers; David Burger; Richard Hoetelmans; Patricia W H Hugen; Sven A Danner; Marchina E Van Der Ende; M M E Schneider; G Schrey; Pieter L Meenhorst; Herman Sprenger; Robbert H Kauffmann; Marielle Jambroes; Margaret A Chesney; Frank de Wolf; Joep M A Lange
Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study.
Archives of internal medicine 2001;161(16):1962-8.
2001: Marielle Jambroes; Gerrit Jan Weverling; Peter Reiss; Sven A Danner; Suzanne Jurriaans; Jacob H Ten Veen; Marchina E Van Der Ende; Martin Schutten; M M E Schneider; R Schuurman; Jan W Mulder; A C Kroes; Joep M A Lange; Frank de Wolf
[HIV-1 therapy in the Netherlands; virological and immunological response to antiretroviral therapy].
Nederlands tijdschrift voor geneeskunde 2001;145(33):1591-7.
2001: Jeanne P Dieleman; M van der Feltz; C H Bangma; Bruno H Ch Stricker; Marchina E Van Der Ende
Papillary necrosis associated with the HIV protease inhibitor indinavir.
Infection 2001;29(4):232-3.
2001: M Bijl; Jeanne P Dieleman; M Simoons; Marchina E Van Der Ende
Low prevalence of cardiac abnormalities in an HIV-seropositive population on antiretroviral combination therapy.
Journal of acquired immune deficiency syndromes (1999) 2001;27(3):318-20.
2001: Robert T Schooley; Nathan Clumeck; Richard Haubrich; M Thompson; Sven A Danner; Marchina E Van Der Ende; Daniel Sereni; F Antunes; D Blake; R E Myers; Margaret Tisdale; Judith Millard; N Mustafa; P Nacci
A dose-ranging study to evaluate the antiretroviral activity and safety of amprenavir alone and in combination with abacavir in HIV-infected adults with limited antiretroviral experience.
Antiviral therapy 2001;6(2):89-96.
2000: David Burger; Patricia W H Hugen; Marchina E Van Der Ende; P van Wijngaarden; Rob E Aarnoutse; Peter Reiss; Joep M A Lange
Once-daily indinavir plus ritonavir: preliminary results of the PIPO study.
AIDS (London, England) 2000;14(16):2621-3.
2000: Marchina E Van Der Ende; Christophe Guillon; Patrick H M Boers; T D Ly; Rob A Gruters; Albert D M E Osterhaus; Martin Schutten
Antiviral resistance of biologic HIV-2 clones obtained from individuals on nucleoside reverse transcriptase inhibitor therapy.
Journal of acquired immune deficiency syndromes (1999) 2000;25(1):11-8.
2000: EH Gisolf; Roelien H Enting; Suzanne Jurriaans; Frank de Wolf; Marchina E Van Der Ende; Richard Hoetelmans; Peter Portegies; Sven A Danner
Cerebrospinal fluid HIV-1 RNA during treatment with ritonavir/saquinavir or ritonavir/saquinavir/stavudine.
AIDS (London, England) 2000;14(11):1583-9.
2000: Martin Schutten; Bernadette van den Hoogen; Marchina E Van Der Ende; Rob A Gruters; Albert D M E Osterhaus; Hubert G M Niesters
Development of a real-time quantitative RT-PCR for the detection of HIV-2 RNA in plasma.
Journal of virological methods 2000;88(1):81-7.
2000: Martin Schutten; Marchina E Van Der Ende; A D Osterhaus
Antiretroviral therapy in patients with dual infection with human immunodeficiency virus types 1 and 2.
The New England journal of medicine 2000;342(23):1758-60.
2000: EH Gisolf; Suzanne Jurriaans; Jolanda Pelgrom; Filip Van Wanzeele; Marchina E Van Der Ende; Kees Brinkman; M J Borst; Frank de Wolf; A J Japour; Sven A Danner
The effect of treatment intensification in HIV-infection: a study comparing treatment with ritonavir/saquinavir and ritonavir/saquinavir/stavudine. Prometheus Study Group.
AIDS (London, England) 2000;14(4):405-13.
2000: Marchina E Van Der Ende; Christophe Guillon; Patrick H M Boers; Rob A Gruters; Paul Racz; Klara Tenner-Racz; Albert D M E Osterhaus; Martin Schutten
Broadening of coreceptor usage by human immunodeficiency virus type 2 does not correlate with increased pathogenicity in an in vivo model.
The Journal of general virology 2000;81(Pt 2):507-13.
1999: Richard Haubrich; M Thompson; Robert T Schooley; W Lang; A Stein; Daniel Sereni; Marchina E Van Der Ende; F Antunes; Douglas Richman; G Pagano; L Kahl; A Fetter; D J Brown; Nathan Clumeck
A phase II safety and efficacy study of amprenavir in combination with zidovudine and lamivudine in HIV-infected patients with limited antiretroviral experience. Amprenavir PROAB2002 Study Team.
AIDS (London, England) 1999;13(17):2411-20.
1999: PJ Gregoor; Teun van Gelder; Marchina E Van Der Ende; J N Ijzermans; Willem Weimar
Cyclosporine and triple-drug treatment with human immunodeficiency virus protease inhibitors.
Transplantation 1999;68(8):1210.
1999: Jeanne P Dieleman; Inge C Gyssens; M J Sturkenboom; H G Niesters; Marchina E Van Der Ende
Substituting nevirapine for protease inhibitors because of intolerance.
AIDS (London, England) 1999;13(11):1423-4.
1999: Marchina E Van Der Ende; Martin Schutten; B Raschdorff; G Grossschupff; Paul Racz; A D Osterhaus; Klara Tenner-Racz
CD4 T cells remain the major source of HIV-1 during end stage disease.
AIDS (London, England) 1999;13(9):1015-9.
1999: Jeanne P Dieleman; Inge C Gyssens; Marchina E Van Der Ende; Siem de Marie; David Burger
Urological complaints in relation to indinavir plasma concentrations in HIV-infected patients.
AIDS (London, England) 1999;13(4):473-8.
1999: Nadine Pakker; E D Kroon; Marijke Th L Roos; Sigrid A Otto; D Hall; Ferdinand W N M Wit; Dörte Hamann; Marchina E Van Der Ende; Frans A Claessen; Robbert H Kauffmann; Peter P Koopmans; Frank P Kroon; C H ten Napel; Herman Sprenger; Hugo M Weigel; Julio S G Montaner; Joep M A Lange; Peter Reiss; P T A Schellekens; Frank Miedema
Immune restoration does not invariably occur following long-term HIV-1 suppression during antiretroviral therapy. INCAS Study Group.
AIDS (London, England) 1999;13(2):203-12.
1998: Jeanne P Dieleman; M E Hillebrand-Haverkort; Marchina E Van Der Ende; Miriam C J M Sturkenboom; Joep M A Lange; Bruno H Ch Stricker
[Lipodystrophy and 'buffalo hump' during treatment with HIV protease inhibitors].
Nederlands tijdschrift voor geneeskunde 1998;142(52):2856-60.
1998: Marchina E Van Der Ende; Martin Schutten; Paul Racz; K Tanner-Racz; A D Osterhaus
[CD4+-T-cells are the predominant source of HIV-1 and HIV-2 production in asymptomatic people and AIDS patients with opportunistic infections].
Nederlands tijdschrift voor geneeskunde 1998;142(40):2230.
1998: Christophe Guillon; Marchina E Van Der Ende; Patrick H M Boers; Rob A Gruters; Martin Schutten; Albert D M E Osterhaus
Coreceptor usage of human immunodeficiency virus type 2 primary isolates and biological clones is broad and does not correlate with their syncytium-inducing capacities.
Journal of virology 1998;72(7):6260-3.
1997: Menno D De Jong; STEFANO VELLA; Andrew Carr; Charles A B Boucher; A Imrie; Martyn French; Jennifer Hoy; S Sorice; S Pauluzzi; F Chiodo; Gerrit Jan Weverling; Marchina E Van Der Ende; P J Frissen; Hugo M Weigel; Robbert H Kauffmann; Joep M A Lange; R Yoon; M Moroni; E Hoenderdos; G Leitz; David A Cooper; D Hall; Peter Reiss
High-dose nevirapine in previously untreated human immunodeficiency virus type 1-infected persons does not result in sustained suppression of viral replication.
The Journal of infectious diseases 1997;175(4):966-70.
1996: Marchina E Van Der Ende; Martin Schutten; T D Ly; Rob A Gruters; A D Osterhaus
HIV-2 infection in 12 European residents: virus characteristics and disease progression.
AIDS (London, England) 1996;10(14):1649-55.
1996: A M van Elsacker-Neile; Frank P Kroon; Marchina E Van Der Ende; M M Salimans; Willy Spaan; A C Kroes
Prevalence of parvovirus B19 infection in patients infected with human immunodeficiency virus.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1996;23(6):1255-60.
1995: Marchina E Van Der Ende; Inge C Gyssens; Siem de Marie
[HIV infection in the Rijnmond area, 1985-1993: more transmission via heterosexual contact and drug use, and more female patients].
Nederlands tijdschrift voor geneeskunde 1995;139(4):188-92.
1994: A C Leenders; Marchina E Van Der Ende; T C van der Ree; Siem de Marie
Cryptococcal meningitis in HIV-infected patients.
AIDS (London, England) 1994;8(12):1741-3.
1994: P H J Frissen; Marchina E Van Der Ende; C H ten Napel; Hugo M Weigel; G S Schreij; Robbert H Kauffmann; Peter P Koopmans; A I Hoepelman; J B de Boer; Gerrit Jan Weverling
Zidovudine and interferon-alpha combination therapy versus zidovudine monotherapy in subjects with symptomatic human immunodeficiency virus type 1 infection.
The Journal of infectious diseases 1994;169(6):1351-5.
1993: T E Sluys; Marchina E Van Der Ende; GR Swart; J Willem O van den Berg; J H Paul Wilson
Body composition in patients with acquired immunodeficiency syndrome: a validation study of bioelectric impedance analysis.
JPEN. Journal of parenteral and enteral nutrition 1993;17(5):404-6.
1992: Marchina E Van Der Ende; A C van Buuren; A C Kroes; F J ten Kate
Failure of antiviral therapy in AIDS-associated cytomegalovirus cholangitis.
Infection 1992;20(6):371-2.
1991: Marchina E Van Der Ende; J J Michiels; A H Mulder; P H Rothbarth
[Non-Hodgkin lymphoma in patients with an HIV-infection].
Nederlands tijdschrift voor geneeskunde 1991;135(23):1045-8.
1990: Teun van Gelder; A C Kroes; Marchina E Van Der Ende
Acute HIV-infection: report of a case and a review of recent developments.
The Netherlands journal of medicine 1990;37(3-4):154-7.
1990: Marchina E Van Der Ende; A C Kroes; J Buitenwerf; Cees L van der Poel
[Aids caused by HIV-2 in The Netherlands].
Nederlands tijdschrift voor geneeskunde 1990;134(10):495-7.